Fangzhou Jianke Launches 'YiLiao'—A Specialized Chronic Disease Management and Health Education Platform to Amplify Professional Medical Voices
In recent years, with the outbreak of the pandemic, public health awareness has gradually risen. When health issues arise, searching for medical information online has become a common habit among the general public. The internet healthcare industry has developed rapidly, and health science popularization has become increasingly diversified. However, health and medical knowledge differs from other types of content; if it lacks professionalism, it can easily adversely affect public health.
The 19th National Congress of the Communist Party of China made major decisions and deployments to implement the Healthy China Strategy. Relevant authorities have successively issued documents such as the Outline of the “Healthy China 2030” Plan and the Healthy China Action (2019–2030), explicitly stating that one of the key tasks of the Healthy China Action is to carry out the initiative for popularizing health knowledge.
On November 24, 2021, Fangzhou Jianke held the H2H Medical Service Ecosystem Conference under the theme “Deepening Chronic Disease Management and Fostering Innovation through Collaboration,” and officially launched its specialized science popularization platform—“Fangzhou MedTalk.” This initiative jointly supports the “Healthy China Action” to enhance the health literacy and health culture of the Chinese population.
Amid normalized pandemic prevention and control measures, public demand for medical and healthcare services has become increasingly diversified, with a pressing need for high-quality, accessible, and practical health education content. To broaden and deepen the scope of physicians’ patient management services, Fangzhou Jianke engages multiple stakeholders—including physicians, healthcare institutions, pharmaceutical companies, and patients—to continuously produce rich, professional, and authoritative medical science popularization content.
On the “Fangzhou Medical Talk” science popularization platform created by Fangzhou Jianke, a large number of physicians contribute to the production of medical science content. The platform has amassed a substantial collection of patient education articles and has organized hundreds of expert-led live streaming sessions.
All content published on the platform is empowered by digital technology, enabling searches by department, disease type, topic, producer, and other categories. All materials are reviewed, verified, and ultimately archived and classified by a professional team.
Unlike other science popularization platforms, “Ark Medical Chat” is grounded in professional expertise, offering diverse educational content through various formats—including illustrated articles, video articles, short videos, and live streams—to enhance public engagement and cater to a wide range of scenarios and audiences.
With content at its core, the "Fangzhou Medical Chat" platform by Fangzhou Jianke has introduced a variety of interactive features. Published content can be simultaneously updated on third-party accounts such as "Jianke Renowned Doctors' Insights" and "Jianke Doctors," enabling real-time sharing, liking, and commenting. From platform content to interactive formats, the "Medical Chat" platform fosters a vibrant yet professional atmosphere for health science popularization, building a public-facing ecosystem that is professional, in-depth, and empathetic.
Currently, the development of short-form video in China has entered a mature stage. Fangzhou Jianke is also actively expanding its presence in the healthcare sector by establishing physician-focused Multi-Channel Network (MCN) agencies. Through its New Media Center, the company has incubated a cohort of 100 branded physicians who deliver professional medical science popularization via multi-format content, including videos and articles. With a focus on patient education, these efforts aim to enhance the interactive value between physicians and patients.
The official launch of the “Fangzhou MedChat” platform will serve as another traffic entry point for Fangzhou Jianke, creating a closed loop from building physicians’ personal brands to converting traffic. On “Fangzhou MedChat,” exclusive personal accounts are created for physicians, featuring consultation information and the publication of professional content. The page presentation builds a multidimensional physician profile, spanning from “content” to “consultation.”
“Building a brand for physicians involves not only helping patients understand doctors and addressing information asymmetry, but also providing science-based health education to support chronic disease management.” This is what Fangzhou Jianke has always advocated and upheld.
By focusing on health science popularization, the “Fangzhou Medical Chat” platform provides an excellent scenario for information sharing and exchange among patient-doctor, doctor-doctor, and medical-pharmaceutical communities. Accessing professional information fosters greater interaction, enabling professional sharing, mutual assistance, and discussion, thereby strengthening the connection between “medicine” and “pharmaceuticals.”
Xie Fangmin, Founder, Chairman, and CEO of Fangzhou Jianke, stated that “Fangzhou Medical Chat” is reshaping the landscape of patient–physician education through socialized and diversified service models, jointly building a new technology-driven platform for medical science popularization and education.
In the future, the “Fangzhou Medical Chat” platform will be built around content-centricity, connecting patients, physicians, pharmaceutical companies, and healthcare institutions, while driving traffic from external channels such as Douyin, Kuaishou, and WeChat Moments. By delivering professional and authoritative health information, the platform aims to attract more users and thereby increase traffic. This approach fosters a virtuous cycle of interaction among users, pharmaceutical companies, and physicians, ultimately achieving a win-win outcome for all stakeholders.
Recently, People’s Daily Online released the “Internet Health Science Popularization Initiative,” which advocates for healthy living concepts and is dedicated to helping the public cultivate healthy lifestyles and habits. It also promotes scientific methods and innovative communication formats, actively fostering a positive atmosphere where science popularization is discussed, appreciated, studied, and applied. Amidst the wave of health science popularization, Fangzhou Jianke’s “Fangzhou Medical Talk” platform leverages its unique professionalism and technological edge to drive the establishment of industry standards for internet health science popularization in China, cultivate high-quality science communicators, deliver high-caliber educational content, and enhance public health literacy.
It is reported that Ark Health, a leader in internet-based chronic disease management services, has creatively proposed the H2H (Hospital to Home) smart healthcare ecosystem model within the current landscape of the online medical industry. This model establishes a distinctive closed-loop internet healthcare service system integrating “medical care, patients, pharmaceuticals, insurance, and health knowledge.” The launch of “Yi Liao,” a specialized platform for popularizing scientific knowledge on chronic diseases, will become a crucial component of Ark Health’s smart healthcare ecosystem. In the future, Ark Health will continue to make positive contributions to national public health.